Position in CADL
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$121,827
-$359 QoQ
Shares Held
24,863
+15.0% QoQ
Ownership
0.034%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 23.44447572698387.ToString("F0")%
Shared 0.ToString("F0")%
None 76.55552427301613.ToString("F0")%
Common Shares in CADL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $16,579,226,864 across 407 Biotechnology names. CADL ranks #230 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
24,150,499 | $3,949,089,591 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
4,311,806 | $3,331,473,778 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,033,156 | $3,140,585,469 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
6,323,752 | $2,092,339,815 | |
| 5 | NUVL |
Nuvalent, Inc.
|
3,088,349 | $316,401,351 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,204,353 | $227,682,931 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
2,363,567 | $177,480,242 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
2,869,728 | $151,292,056 |
All Filings in CADL
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $121,827 | 24,863 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $122,186 | 21,626 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $90,953 | 17,834 | Shares | Defined | 2025-11-26 | |
| 2025-06-30 | $98,835 | 19,533 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $80,585 | 14,263 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $90,497 | 10,426 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $62,723 | 9,051 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $120,018 | 19,358 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $348 | 221 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $306 | 209 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $186 | 203 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $234 | 186 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $251 | 186 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $332 | 186 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $4,578 | 1,458 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,040 | 1,247 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $17,239 | 3,387 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $19,776 | 2,529 | Shares | Defined | 2022-02-11 | |
| No filing history on record for this holder in this stock. | ||||||